Gregg H. Alton, EVP, Corporate & Med Affairs at GILEAD SCIENCES INC (GILD), sold 12,000 shares at $107.18 ($1.3M) on 2015-12-01, disclosed to the SEC on 2015-12-03.
Scheduled sale ($1.3M) by EVP, Corporate & Med Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.35 | 5,995 | $632K | 49.6% |
| 2 | $106.54 | 4,705 | $501K | 39.4% |
| 3 | $107.18 | 1,300 | $139K | 11.0% |
| Total | $106.01 avg | 12,000 | $1.3M | 100% |
| Filing → |
| GILD | SELL | 2018-02-05 | $4.2M | — | Filing → |
| GILD | SELL | 2018-01-16 | $2.4M | — | Filing → |
| GILD | SELL | 2018-01-04 | $1.5M | — | Filing → |